• A Headlands Research Site   
    Headlands Research White Logo
    • About Headlands Research
    • Capabilities
    • Site Network
    • Team
Toronto Memory Program
  • Facebook
  • Twitter
  • LinkedIn
Donate Now
  • About Us
    • Medical Director
    • Our Team
    • Our Facility
    • Careers
  • Patients
    • Memory Clinic
    • Movement Disorders Clinic
    • Free Memory Assessment
    • Frequently Asked Questions
    • Clinical Trials
  • Physicians
  • Sponsors
  • Clinical Trials
    • Current Studies
    • Free Memory Assessment
    • Frequently Asked Questions
  • Media
  • Contact

Media

 

Dr. Sharon Cohen on CanadaTalks with Matt Gurney

Neurologist Dr. Sharon Cohen joined Matt Gurney on CanadaTalks

Neurologist Dr. Sharon Cohen joined Matt Gurney on CanadaTalks SiriusXM for a discussion of the latest updates in the diagnosis and treatment of Alzheimer’s disease.

To hear this discussion, click on the link below.

https://soundcloud.com/canadatalks/dr-sharon-cohen-talks-to-matt-gurney-about-alzeimers

Recent Posts

  • Hope and anxiety surround new Alzheimer’s drug lecanemab
  • Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns
  • A New Drug Could Slow Alzheimer’s Disease, Data Show
  • A potential breakthrough in Alzheimer’s research needs Canadians’ help to move forward
  • An experimental Alzheimer’s drug could be approved next year. But it comes with risks
  • Ontario not ready for new Alzheimer’s treatment
  • Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC
  • Dr. Sharon Cohen on Medcan’s podcast series called Eat, Move, Think!
  • Dr. Sharon Cohen on CanadaTalks with Matt Gurney
  • CTV News Channel with Dr. Sharon Cohen on FDA approval of Aducanumab

Media Requests

If your organization would like to make a request, please use one of the following two options:

  • Call: (416) 386-9761 Ext. 364
  • Email: media@memorydisorders.ca
Latest Tweets

Dr. Sharon Cohen sharing key Alzheimer's research updates with Etobicoke PROBUS Club this morning. We are thrilled to keep the community ...informed about the latest advancements in understanding and addressing Alzheimer's. 🧠

Image for the Tweet beginning: Dr. Sharon Cohen sharing key Twitter feed image.
Reply on Twitter 1725173836050563505 Retweet on Twitter 1725173836050563505 0 Like on Twitter 1725173836050563505 1 Twitter 1725173836050563505

Dementia affects individuals uniquely, with symptoms varying by type, and Alzheimer's disease being the most common. Ten common warning ...signs, such as memory loss and mood changes, may indicate dementia. If you have concerns, reach out to us for information and support.

Image for the Tweet beginning: Dementia affects individuals uniquely, with Twitter feed image.
Reply on Twitter 1723040095341568247 Retweet on Twitter 1723040095341568247 0 Like on Twitter 1723040095341568247 1 Twitter 1723040095341568247
Load More...
Toronto Memory Program

A Headlands Research Company

  • Facebook
  • Twitter
  • LinkedIn
  • About Us
  • Patients
  • Physicians
  • Sponsors
  • Studies
  • In the Media
  • Contact Us


Monday - Friday: 8am - 4pm


Headlands Research Logo



© 2023 Toronto Memory Program. All rights reserved.